Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.04 B MXN
3.74 M MXN
62.81 M
About InflaRx N.V.
Sector
Industry
CEO
Niels Christoph Riedemann
Website
Headquarters
Jena
Founded
2007
ISIN
NL0012661870
FIGI
BBG00LCX3334
InflaRx NV is a clinical-stage biopharmaceutical company, which engages in the discovery and development of inhibitors of the complement activation factor known as C5a and its receptor C5aR. Its primary product candidate is Vilobelimab. The company was founded by Niels Christoph Riedemann, Renfeng Guo, and Nicolas Fulpius in December 2007 and is headquartered in Jena, Germany.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of IFRX/N is 16.00 MXN — it has decreased by −35.33% in the past 24 hours. Watch InflaRx N.V. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BMV exchange InflaRx N.V. stocks are traded under the ticker IFRX/N.
We've gathered analysts' opinions on InflaRx N.V. future price: according to them, IFRX/N price has a max estimate of 186.15 MXN and a min estimate of 37.23 MXN. Watch IFRX/N chart and read a more detailed InflaRx N.V. stock forecast: see what analysts think of InflaRx N.V. and suggest that you do with its stocks.
IFRX/N reached its all-time high on Dec 31, 2018 with the price of 683.46 MXN, and its all-time low was 16.00 MXN and was reached on Aug 25, 2025. View more price dynamics on IFRX/N chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
IFRX/N stock is 54.62% volatile and has beta coefficient of 0.69. Track InflaRx N.V. stock price on the chart and check out the list of the most volatile stocks — is InflaRx N.V. there?
Today InflaRx N.V. has the market capitalization of 1.60 B, it has decreased by −0.94% over the last week.
Yes, you can track InflaRx N.V. financials in yearly and quarterly reports right on TradingView.
InflaRx N.V. is going to release the next earnings report on Oct 30, 2025. Keep track of upcoming events with our Earnings Calendar.
IFRX/N earnings for the last quarter are −4.64 MXN per share, whereas the estimation was −4.64 MXN resulting in a 0.00% surprise. The estimated earnings for the next quarter are −3.26 MXN per share. See more details about InflaRx N.V. earnings.
InflaRx N.V. revenue for the last quarter amounts to 871.33 K MXN, despite the estimated figure of 871.33 K MXN. In the next quarter, revenue is expected to reach 1.49 M MXN.
IFRX/N net income for the last quarter is −306.75 M MXN, while the quarter before that showed −179.27 M MXN of net income which accounts for −71.11% change. Track more InflaRx N.V. financial stats to get the full picture.
No, IFRX/N doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 27, 2025, the company has 74 employees. See our rating of the largest employees — is InflaRx N.V. on this list?
Like other stocks, IFRX/N shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade InflaRx N.V. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So InflaRx N.V. technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating InflaRx N.V. stock shows the sell signal. See more of InflaRx N.V. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.